Finance

Lists
0A9W:LON
Organon & Co
13,76 US$
-0,07%
(-0,010) 1D
15 ოქტ, 19:14:55 GMT+1  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for 0A9W...
Open
13,74 US$
High
13,77 US$
Low
13,73 US$
Mkt. cap
3,61 მლრდ.
Avg. vol.
3,79 ათ.
Volume
2,07 ათ.
52-wk high
13,84 US$
52-wk low
5,72 US$
No. of employees
10 ათ.
Open
13,74 US$
High
13,77 US$
Low
13,73 US$
Mkt. cap
3,61 მლრდ.
Avg. vol.
3,79 ათ.
Volume
2,07 ათ.
52-wk high
13,84 US$
52-wk low
5,72 US$
No. of employees
10 ათ.
News stories
From web sources and news partners
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 ათ.
Founded1923
HeadquartersJersey City, ნიუ-ჯერსი, ამერიკის შეერთებული შტატები
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,60 მლრდ.
1,51 მლრდ.
1,46 მლრდ.
1,56 მლრდ.
Cost of goods sold
733,00 მლნ.
741,00 მლნ.
670,00 მლნ.
711,00 მლნ.
Cost of revenue
733,00 მლნ.
741,00 მლნ.
670,00 მლნ.
711,00 მლნ.
Research and development expenses
84,00 მლნ.
91,00 მლნ.
93,00 მლნ.
90,00 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
415,00 მლნ.
431,00 მლნ.
424,00 მლნ.
434,00 მლნ.
Operating expense
499,00 მლნ.
522,00 მლნ.
517,00 მლნ.
524,00 მლნ.
Total operating expenses
1,23 მლრდ.
1,26 მლრდ.
1,19 მლრდ.
1,24 მლრდ.
Operating income
370,00 მლნ.
244,00 მლნ.
273,00 მლნ.
323,00 მლნ.
Other non operating income
30,00 მლნ.
-18,00 მლნ.
15,00 მლნ.
-3,00 მლნ.
EBT including unusual items
243,00 მლნ.
-148,00 მლნ.
213,00 მლნ.
183,00 მლნ.
EBT excluding unusual items
255,00 მლნ.
103,00 მლნ.
170,00 მლნ.
210,00 მლნ.
Income tax expense
83,00 მლნ.
57,00 მლნ.
67,00 მლნ.
75,00 მლნ.
Effective tax rate
34,16%
-38,51%
31,46%
40,98%
Other operating expenses
-
-
-
-
Net income
160,00 მლნ.
-205,00 მლნ.
146,00 მლნ.
108,00 მლნ.
Net profit margin
9,99%
-13,60%
10,00%
6,93%
Earnings per share
1,01
0,63
0,71
0,85
Interest and investment income
-
-
-
-
Interest expense
-128,00 მლნ.
-121,00 მლნ.
-111,00 მლნ.
-108,00 მლნ.
Net interest expenses
-128,00 მლნ.
-121,00 მლნ.
-111,00 მლნ.
-108,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
462,00 მლნ.
340,00 მლნ.
359,00 მლნ.
403,00 მლნ.
Gain or loss from assets sale
-
-
-81,00 მლნ.
-
AI content may include mistakes. Learn more
Google აპები